Hangzhou Tigermed Consulting Co., Ltd. (3347.HK)
HKD 27.2
(1.68%)
HKD 27.2
(1.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 29.68 Billion CNY | 8.14% |
| 2022 | 27.44 Billion CNY | 15.61% |
| 2021 | 23.74 Billion CNY | 21.71% |
| 2020 | 19.5 Billion CNY | 158.95% |
| 2019 | 7.53 Billion CNY | 76.01% |
| 2018 | 4.27 Billion CNY | 19.44% |
| 2017 | 3.58 Billion CNY | 50.03% |
| 2016 | 2.38 Billion CNY | 48.34% |
| 2015 | 1.61 Billion CNY | 18.59% |
| 2014 | 1.35 Billion CNY | 68.02% |
| 2013 | 808.01 Million CNY | 10.26% |
| 2012 | 732.83 Million CNY | 292.4% |
| 2011 | 186.75 Million CNY | 55.75% |
| 2010 | 119.91 Million CNY | 77.94% |
| 2009 | 67.38 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 30.41 Billion CNY | 1.15% |
| 2024 Q1 | 30.07 Billion CNY | 1.31% |
| 2024 Q3 | 30.27 Billion CNY | -0.46% |
| 2023 Q3 | 30.07 Billion CNY | 1.37% |
| 2023 Q2 | 29.66 Billion CNY | 5.31% |
| 2023 FY | 29.68 Billion CNY | 8.14% |
| 2023 Q4 | 29.68 Billion CNY | -1.3% |
| 2023 Q1 | 28.17 Billion CNY | 2.64% |
| 2022 Q3 | 27.14 Billion CNY | 5.59% |
| 2022 FY | 27.44 Billion CNY | 15.61% |
| 2022 Q4 | 27.44 Billion CNY | 1.13% |
| 2022 Q1 | 24.8 Billion CNY | 4.47% |
| 2022 Q2 | 25.7 Billion CNY | 3.63% |
| 2021 Q4 | 23.74 Billion CNY | 8.13% |
| 2021 Q3 | 21.95 Billion CNY | 3.46% |
| 2021 Q2 | 21.22 Billion CNY | 4.63% |
| 2021 Q1 | 20.28 Billion CNY | 3.98% |
| 2021 FY | 23.74 Billion CNY | 21.71% |
| 2020 Q3 | 18.82 Billion CNY | 103.18% |
| 2020 FY | 19.5 Billion CNY | 158.95% |
| 2020 Q4 | 19.5 Billion CNY | 3.59% |
| 2020 Q2 | 9.26 Billion CNY | 12.44% |
| 2020 Q1 | 8.24 Billion CNY | 9.42% |
| 2019 Q3 | 6.31 Billion CNY | -1.72% |
| 2019 Q1 | 4.4 Billion CNY | 2.89% |
| 2019 Q2 | 6.42 Billion CNY | 45.8% |
| 2019 FY | 7.53 Billion CNY | 76.01% |
| 2019 Q4 | 7.53 Billion CNY | 19.38% |
| 2018 Q2 | 3.95 Billion CNY | 0.54% |
| 2018 Q1 | 3.93 Billion CNY | 9.8% |
| 2018 FY | 4.27 Billion CNY | 19.44% |
| 2018 Q4 | 4.27 Billion CNY | 4.95% |
| 2018 Q3 | 4.07 Billion CNY | 3.09% |
| 2017 Q4 | 3.58 Billion CNY | 5.82% |
| 2017 Q2 | 3.23 Billion CNY | 31.71% |
| 2017 Q1 | 2.45 Billion CNY | 2.97% |
| 2017 FY | 3.58 Billion CNY | 50.03% |
| 2017 Q3 | 3.38 Billion CNY | 4.54% |
| 2016 Q4 | 2.38 Billion CNY | 11.71% |
| 2016 Q3 | 2.13 Billion CNY | -0.16% |
| 2016 FY | 2.38 Billion CNY | 48.34% |
| 2016 Q2 | 2.14 Billion CNY | 3.67% |
| 2016 Q1 | 2.06 Billion CNY | 28.29% |
| 2015 FY | 1.61 Billion CNY | 18.59% |
| 2015 Q2 | 1.14 Billion CNY | -0.34% |
| 2015 Q1 | 1.15 Billion CNY | -15.13% |
| 2015 Q3 | 1.39 Billion CNY | 21.51% |
| 2015 Q4 | 1.61 Billion CNY | 15.39% |
| 2014 Q4 | 1.35 Billion CNY | 12.8% |
| 2014 Q3 | 1.2 Billion CNY | 36.39% |
| 2014 Q2 | 882.41 Million CNY | -0.19% |
| 2014 Q1 | 884.09 Million CNY | 9.42% |
| 2014 FY | 1.35 Billion CNY | 68.02% |
| 2013 Q2 | 732.57 Million CNY | -2.64% |
| 2013 Q1 | 752.42 Million CNY | 2.67% |
| 2013 Q4 | 808.01 Million CNY | 7.3% |
| 2013 FY | 808.01 Million CNY | 10.26% |
| 2013 Q3 | 753.07 Million CNY | 2.8% |
| 2012 Q4 | 732.83 Million CNY | 3.43% |
| 2012 FY | 732.83 Million CNY | 292.4% |
| 2012 Q2 | 213.91 Million CNY | 0.0% |
| 2012 Q3 | 708.54 Million CNY | 231.22% |
| 2011 Q4 | 186.75 Million CNY | 0.0% |
| 2011 FY | 186.75 Million CNY | 55.75% |
| 2010 FY | 119.91 Million CNY | 77.94% |
| 2009 FY | 67.38 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Life Healthcare Group Limited | 336.13 Million HKD | -8730.033% |
| China Biotech Services Holdings Limited | 662.36 Million HKD | -4381.045% |